FIELD: pharmacy.
SUBSTANCE: invention relates to methods for post-stroke recovery and blood pressure reduction for patient with stroke, who is in need of such treatment, comprising introduction of an effective amount of a pharmaceutical composition containing a short-term acting dihydropyridine compound, represented by clevidipine or a pharmaceutically acceptable salt or ester thereof. The pharmaceutical composition is an emulsion comprising a lipid and an emulsifier. Methods for pharmaceutical compositions preparations are also described.
EFFECT: optimal ratio of efficiency, accuracy and safety of rapid blood pressure reduction for stroke patients, with minimal neurological impairment.
32 cl
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470907C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470908C2 |
| COMPOSITIONS AND METHODS FOR IMPROVEMENT OF FORECAST OF PERSON WITH SUBARACHNOIDAL HEMORRHAGE | 2012 |
|
RU2597791C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| APPLICATION OF ORGANIC COMPOUNDS | 2005 |
|
RU2426532C2 |
| CLEVIDIPINE NANOPARTICLES AND THEIR PHARMACEUTICAL COMPOSITIONS | 2015 |
|
RU2759673C2 |
| COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF STROKE | 2013 |
|
RU2650963C2 |
| COMPOSITIONS AND METHODS FOR USING PHORBOL ETHERS FOR TREATMENT OF STROKE | 2013 |
|
RU2775972C2 |
| CHLORIDE SALT OF PEPTIDE TAT-NR2B9c COMPOSITION, BASED THEREON AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2707885C2 |
| NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
